Vitamin D supplementation beneficial for glucose markers among postmenopausal women

Written By :  Aditi
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-08-24 06:00 GMT   |   Update On 2023-08-24 10:57 GMT

The increase in the prevalence of type 2 diabetes is closely linked to the upsurge in obesity. Obesity and associated metabolic syndrome is also linked to impaired glucose tolerance. Epidemiological studies have linked low vitamin D levels to the pathogenesis of diabetes and also supported the favorable effects of adequate vitamin D intake on reducing the risk of T2D.

Dr Hao L et al. and colleagues have recently found in a new study that among postmenopausal women, Vitamin D is beneficial for glucose markers but not obesity.

The  findings of the study have been  published in the Journal  Clinical  Therapeutics.

The effect of vitamin D effect on glucose markers and obesity in postmenopausal women remains controversial. There needs to be more data available on the dosage and duration of vitamin D for optimal efficacy in postmenopausal women. This background was researched in the present study using databases without language restrictions. The data was collected from PubMed/MEDLINE, Web of Science, EMBASE, and Scopus.

Advertisement

A total of Nine eligible articles with 12 comparisons qualified for the final quantitative analysis and the findings could be summarised as follows:

  • An overall decrease was noted in fasting blood glucose, homeostatic model assessment for insulin resistance, insulin and glycosylated haemoglobin with a weighted mean difference of -3.56 mg/dL; -1.168 mm; -2.26 units; and -0.41%, respectively after vitamin D administration in postmenopausal women.
  • In subgroup analyses, there was a notable decrease in fasting blood glucose when the intervention course was ˃6 months and dosage ≤1000 IU/d with WMD, -3.48 mg/dL.
  • Vitamin D was not associated with body mass index, weight, or waist circumference.

The researchers have concluded that Vitamin D is beneficial for glucose markers but not obesity in postmenopausal women.

However a personalized dosage plan for vitamin D should be implemented for postmenopausal women based on the target clinical outcomes.

Further reading:

DOI: https://doi.org/10.1016/j.clinthera.2023.07.009

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News